How do you think the new GigE standards will influence the machine vision industry?
Respond or ask your question now!
2006 FEB 9 - (NewsRx.com) -- Guardian Technologies International, Inc., (GDTI), a technology developer of intelligent imaging informatics (3i) solutions, announced that its advanced research department has created a breakthrough in image processing with the potential to improve the diagnostic characteristics of medical images which, the company says, should result in easier and speedier diagnoses, decreased misreads, and greater workflow efficiency for the diagnosing physician.
Guardian offered a sneak preview of this new technology in December 2005 at the Radiology Society of North America (RSNA) conference held in Chicago, Illinois. RSNA is the largest radiographic conference in the world with an attendance of over 60,000 medical professionals, scientists, and administrators. Guardian's research scientists were able to meet with and present to a group of physicists, radiologists, researchers, and practitioners from leading corporations and research universities in the healthcare imaging field.
The 3i technology is able to detect and distinguish different types of organic compounds contained in images from a wide array of sources, including x-ray, computed tomography, and hyper spectral data types. Since the human body is made of organic compounds, the adaptation of the scientific principles behind Guardian's PinPoint threat detection technology to medical image analysis follows naturally, the company says. Guardian has discovered and implemented a method that identifies a unique signature within images - like a latent fingerprint - that is unique to individual types of materials. The two dominant interactions in this process are the photoelectric and Compton effects. Guardian's software decodes the encoded signatures, making accurate identification of specific items within images possible.
Bill Donovan, Guardian's president and COO, noted, "We are initially addressing the business opportunities for x-ray and pathology-based image processing. The 3i imaging technology combined with our FlowPoint workflow and image management solution is a significant step towards the fulfillment of Guardian's vision for successfully differentiating its product in the medical market.
"We are particularly focusing on mammography and chest studies, as they represent a significantly large volume of studies performed each year, with an accompanying need for improved diagnostic capabilities. With the aging population, healthcare needs and costs will continue to grow at unprecedented levels. We believe that these factors will drive demand for our FlowPoint and 3i integrated solution for managing cost-effective healthcare delivery. It is our intention to develop products that will address this imaging market which Frost & Sullivan estimates has a market size of more than $100.7 million for computer-aided detection alone in 2006. They also estimate that this new imaging market is growing by 11.5% per year and is expected to reach $155.6 million by the year 2010."